用于肝细胞癌筛查与监测的简化MRI
临床指南推荐高危成人每半年行肝脏超声监测,以发现可能治愈的肝细胞癌(HCC);但肝硬化与体型肥胖可影响超声对肝脏病灶的显示并降低其敏感度。简化MRI是专为早期HCC检测设计的缩短序列方案,已研究非增强、动态增强和肝胆期增强三种策略;回顾性研究显示模拟简化MRI对早期HCC具有高敏感度和特异度,但多在非监测队列中。
要点
- 指南推荐高危成人每半年行肝脏超声监测,以发现可能治愈的HCC。
- 肝硬化与体型肥胖可影响超声对肝脏病灶的显示,降低监测敏感度。
- 简化MRI序列少于完整多期MRI,专为识别超声可能漏诊的小型可治愈HCC设计。
核心结论
- 简化MRI是专为早期HCC检测设计的缩短MRI方案,已作为可能提供高敏感度和特异度的替代监测选择被提出。
- 回顾性研究显示,模拟简化MRI对早期HCC具有高敏感度和特异度,但多在非监测队列中。
- 若在监测人群中获得科学证据支持,采用简化MRI可能通过提高HCC早期检出、使患者获得有效治疗并可能延长生存,从而推进临床实践。
研究设计与样本
- 本文为综述,汇总三种简化MRI策略:非增强、动态对比剂增强和肝胆期对比剂增强简化MRI。
- 简化MRI方案包含的序列少于完整多期MRI检查。
临床应用与阅片要点
- 临床实践指南推荐对HCC高危成人(如肝硬化患者及部分慢性乙型肝炎感染者)每半年行肝脏超声监测。
- 肝硬化与体型肥胖可影响超声对肝脏病灶的显示并降低该方式监测的敏感度,超声对早期HCC的低敏感度可导致诊断延迟和死亡率增加。
局限性
- 本文引用的简化MRI证据主要来自回顾性研究,且多在非监测队列中;其在监测人群中的价值尚需科学证据支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
To detect potentially curable hepatocellular carcinoma (HCC), clinical practice guidelines recommend semiannual surveillance US of the liver in adult patients at risk for developing this malignancy, such as those with cirrhosis and some patients with chronic hepatitis B infection. However, cirrhosis and a large body habitus, both of which are increasingly prevalent in the United States and the rest of the world, may impair US visualization of liver lesions and reduce the sensitivity of surveillance with this modality. The low sensitivity of US for detection of early-stage HCC contributes to delayed diagnosis and increased mortality. Abbreviated MRI, a shortened MRI protocol tailored for early-stage detection of HCC, has been proposed as an alternative surveillance option that provides high sensitivity and specificity. Abbreviated MRI protocols include fewer sequences than a complete multiphase MRI examination and are specifically designed to identify small potentially curable HCCs that may be missed at US. Three abbreviated MRI strategies have been studied: (a) nonenhanced, (b) dynamic contrast material-enhanced, and (c) hepatobiliary phase contrast-enhanced abbreviated MRI. Retrospective studies have shown that simulated abbreviated MRI provides high sensitivity and specificity for early-stage HCC, mostly in nonsurveillance cohorts. If it is supported by scientific evidence in surveillance populations, adoption of abbreviated MRI could advance clinical practice by increasing early detection of HCC, allowing effective treatment and potentially prolonging life in the growing number of individuals with this cancer. Online supplemental material is available for this article. ©RSNA, 2020.
引用
- An JY, Peña MA, Cunha GM, et al. Abbreviated MRI for Hepatocellular Carcinoma Screening and Surveillance. Radiographics. 2020. PMID: 33136476. doi:10.1148/rg.2020200104
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。